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Abstract
We consider the estimation of the effect of a policy or treatment, using panel data
where different groups of units are exposed to the treatment at different times. We focus on
parameters aggregating instantaneous and dynamic treatment effects, with a clear welfare
interpretation. We show that under parallel trends conditions, these parameters can be
unbiasedly estimated by a weighted average of differences-in-differences, provided that at
least one group is always untreated, and another group is always treated. Our estimators are
valid if the treatment effect is heterogeneous, contrary to the commonly-used event-study
regression.
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1 Introduction
We consider the estimation of the effect of a policy or treatment on an outcome, using a panel
of groups (indexed by g hereafter) that are exposed to the policy at different times (indexed by
t hereafter). It is often appealing to study the dynamic effects of the policy, rather than just
focusing on its instantaneous effect at the time of implementation. To do so, a commonly-used
method, first proposed by Autor (2003), is to regress the outcome on group fixed effects, time
fixed effects, the value of the treatment in group g and period t, and lags of the treatment in group
g. Hereafter, we refer to this regression as the event-study regression. Intuitively, the coefficient
of the contemporaneous treatment should estimate its instantaneous effect, while the coefficients
of the lagged treatments should estimate its dynamic effects. However, Abraham and Sun (2020)
have shown that those estimators are only valid if the treatment effect is homogenous over groups
and time, the latter assumption being especially unappealing when one is interested in estimating
dynamic effects.1 Instead, we propose to use differences-in-differences (DID) estimators. As the
event-study regression, such estimators rely on the standard parallel trends assumption. But
unlike it, they remain valid if the treatment effect is heterogeneous.
In our panel data setting, there is a wealth of instantaneous and dynamic treatment effects one
could estimate, and some aggregation is in order to improve power. Welfare analysis is a natural
guide to perform said aggregation (see Manski, 2005). Specifically, we assume units’ utility
is additively separable in the outcome, and adopt the perspective of a planner interested in
comparing the population’s expected average intertemporal utility under the actual treatments
received and under the scenario where all groups keep all along the same treatment as in the first
period of the panel. Our parameter of interest is the difference between these two expectations,
hereafter referred to as the actual-versus-status-quo parameter. It measures the welfare effects
of the policy changes that occurred over the period.
We start by focusing on staggered adoption designs, where groups adopt the treatment at dif-
ferent time periods and cannot switch out of the treatment after adoption. Many applications
do not fall into this special case, but it is much simpler to analyze than the general case, so we
focus on it first for the sake of exposition. We show that if at least one group is still untreated
at the end of the panel, the actual-versus-status-quo parameter can be unbiasedly estimated.
Our estimator proceeds in two steps. We start by estimating the average effect of having started
to receive the treatment ` periods ago, from ` = 0 (corresponding to the instantaneous treat-
ment effect) to the highest value of ` observed in the data. For each `, our estimator DID` is a
weighted average, across t, of DID estimators comparing the t − ` − 1 to t outcome evolution,
in groups that become treated in t− ` and in groups not yet treated in t. Then, our estimator
1Their result is a generalization of that in de Chaisemartin and D’Haultfœuille (2020), who show that a similar
result holds for the static two-way fixed effects regression without the lagged treatments.
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of the actual-versus-status-quo parameter is a weighted average of the DID` estimators. If all
groups are treated at the end of the panel, a truncated version of our actual-versus-status-quo
parameter can still be unbiasedly estimated, where the truncation happens at the last period
when at least one group is still untreated. In staggered adoption designs, the DID` estimators
are computed by the Stata did_multiplegt package (see de Chaisemartin et al., 2019).
We then consider general designs, where groups may switch in and out of the treatment at any
time. We start by showing that if there is at least one group that is always untreated and
another group that is always treated, the actual-versus-status-quo parameter can be unbiasedly
estimated. Our estimator is a weighted average, across t and `, of DID estimators comparing the
t− `− 1 to t outcome evolution, in groups whose treatment first changed in t− ` and in groups
whose treatment has not changed yet in t. Again, if there is no group untreated till the end of the
panel, or no group treated till the end of the panel, a truncated version of our parameter can be
unbiasedly estimated. In long panels, or in instances where groups change treatment frequently,
the truncation may happen early in the panel, and the truncated parameter could then be very
different from the original target parameter. Then, we consider an assumption on dynamic
effects, and show that under this assumption, one can unbiasedly estimate a parameter that
will often be closer to the parameter the planner needs to know to evaluate the policy changes
that took place over the period. This assumption amounts to ruling out dynamic effects beyond
k-lags, for a given k that the analyst should choose based on the context. Ruling out dynamic
effects beyond a certain lag is an assumption that is implicitly made in event-study regressions:
without it, such regressions are not identified (Borusyak and Jaravel, 2017; Schmidheiny and
Siegloch, 2020).
Abraham and Sun (2020) and Callaway and Sant’Anna (2018) have also proposed DID estimators
of instantaneous and dynamic treatment effects in panels with multiple groups and periods. Our
paper differs from those on at least three dimensions. First and foremost, those papers only
consider staggered adoption designs, while we also consider general designs, where groups may
switch in and out of the treatment at any time. Our estimators can also be easily extended
to non-binary treatments, unlike theirs. In a survey of all the papers using regressions with
group and time fixed effects published by the AER between 2010 and 2012, de Chaisemartin
and D’Haultfœuille (2020) find that less than 10% have a staggered adoption design. Therefore,
our estimators can be used in a much larger set of empirical applications. Second, our paper is
the first to use welfare analysis to guide the aggregation of instantaneous and dynamic treatment
effects. Callaway and Sant’Anna (2018) propose several interesting aggregation methods, but
the estimands they propose differ from our actual-versus-status-quo parameter, and they do not
have a clear welfare interpretation. The same applies to the aggregation method in Abraham
and Sun (2020). Aggregation is especially important outside of staggered designs. With T time
periods in the panel, there are only T + 1 possible treatment trajectories in a staggered design,
3
against 2T in general designs. Hence, we can expect the estimation of the difference between
the outcome of two such trajectories to be very noisy. Third, even in staggered designs, our
estimators differ from those in Abraham and Sun (2020) and Callaway and Sant’Anna (2018).
To estimate the treatment effect at date t in groups that became treated at date t − `, we use
as controls all groups not yet treated at t, while Callaway and Sant’Anna (2018) use the never
treated groups, and Abraham and Sun (2020) use the never treated groups or the groups that
become treated last if there are no never treated groups. Our control group is larger, so we can
expect our estimators to be more precise.
This paper is also related to previous work of ours. In staggered designs, the DID0 estimator
we propose in this paper is equivalent to the DIDM estimator we proposed in de Chaisemartin
and D’Haultfœuille (2020). Outside of staggered designs, the DIDM estimator is equivalent to
the estimator we propose in this paper under the assumption of no dynamic effects.
This paper is organized as follows. Section 2 introduces the notation and the assumptions we
maintain throughout the paper. Section 3 considers the case of staggered adoption designs.
Section 4 considers general designs.
2 Set-up
One considers observations that can be divided into G groups and T periods. Time periods are
indexed by t ∈ {1, ..., T}. Groups are indexed by g ∈ {1, ..., G}. There are Ng,t > 0 observations
in group g at period t. The data may be an individual-level panel or repeated cross-section data
set where groups are, say, individuals’ county of birth. The data could also be a cross-section
where cohort of birth plays the role of time. It is also possible that for all (g, t), Ng,t = 1, e.g. a
group is one individual or firm.
One is interested in measuring the effect of a treatment on some outcome. Throughout the
paper we assume that treatment is binary, but our results can easily be generalized to any
ordered treatment. Then, for every (i, g, t) ∈ {1, ..., Ng,t} × {1, ..., G} × {1, ..., T}, let Di,g,t
denote the treatment status of observation i in group g at period t. We focus on sharp designs,
where the treatment does not vary within (g, t) cells.
Assumption 1 (Sharp design) ∀(i, g, t) ∈ {1, ..., Ng,t} × {1, ..., G} × {1, ..., T}, Di,g,t = Dg,t.2
Assumption 1 is for instance satisfied when the treatment is a group-level variable, for instance
a county- or a state-law, or when Ng,t = 1. Then, let Dg = (Dg,1, ..., Dg,T ) be a 1 × T vector
2Assumptions 1, 3, 4, 6, 7, 9-k, and Theorems 1 and 2 have equalities and inequalities involving random
variables. Implicitly, these equalities and inequalities are assumed to hold with probability 1.
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stacking the treatments of group g from period 1 to T . For all t, let Dg,t = (Dg,1, ..., Dg,t) be a
1× t vector stacking the treatments of group g from period 1 to t.
For all d ∈ {0, 1}T , let Yg,t(d) denote the average potential outcome of group g at period t,
if the treatments of group g from period 1 to T are equal to d. This notation allows for the
possibility that group g’s outcome at time t be affected by her past and future treatments. Some
groups may have already been treated prior to period 1, the first period in the data, and those
treatments may still affect some of their period-1-to-T outcomes. However, we cannot estimate
such dynamic effects, as treatments and outcomes are not observed for those periods, so we do
not account for this potential dependency in our notation. Finally, we let Yg,t = Yg,t(Dg) denote
the observed outcome, and for all t we let 0t denote a vector of t zeros.
Assumption 2 (Independence between groups) The G vectors (Dg, (Yg,1(d), ..., Yg,T (d))d∈{0,1}T )
are mutually independent.
We consider the treatment and potential outcomes of each (g, t) cell as random variables. For
instance, aggregate random shocks may affect the potential outcomes of group g at period t, and
that cell’s treatment may also be random. The expectations below are taken with respect to the
distribution of those random variables. Under Assumption 2, the treatments and potential out-
comes of a group may be correlated over time, but the potential outcomes and treatments of dif-
ferent groups have to be independent, a commonly made assumption in difference-in-differences
(DID) designs (see Bertrand et al., 2004).
Assumption 3 (No Anticipation) For all g, for all d ∈ {0, 1}T , Yg,t(d) = Yg,t(d1, ..., dt).
Assumption 3 requires that a group’s current outcome do not depend on her future treatments,
the so-called no-anticipation hypothesis, see, e.g., Abbring and Van den Berg (2003). Under
Assumption 3, Yg,t = Yg,t(Dg,t).
Hereafter, we refer to Yg,t(0t), the potential outcome that group g will obtain at period t if she
remains untreated from period 1 to t as the never-treated potential outcome. We consider two
assumptions on that outcome.
Assumption 4 (Strong exogeneity) ∀t ≥ 2, E(Yg,t(0t)−Yg,t−1(0t−1)|Dg) = E(Yg,t(0t)−Yg,t−1(0t−1)).
Assumption 4 requires that the shocks affecting a group’s never-treated potential outcome be
mean independent of her treatments. For instance, this rules out cases where a group gets treated
because it experiences some negative shocks, the so-called Ashenfelter’s dip (see Ashenfelter,
1978). Assumption 4 is related to the strong exogeneity condition in panel data models.
Assumption 5 (Common trends) ∀t ≥ 2, E(Yg,t(0t)− Yg,t−1(0t−1)) does not vary across g.
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Assumption 5 requires that in every group, the expectation of the never-treated outcome follow
the same evolution over time. It is a generalization of the standard parallel trends assumption
in DID models (see, e.g., Abadie, 2005) to our set-up allowing for dynamic effects. Abraham
and Sun (2020), Athey and Imbens (2018), and Callaway and Sant’Anna (2018) also consider
that assumption.
3 Staggered adoption designs
Throughout this section, we assume that the treatment follows a staggered adoption design,
where groups can switch in but not out of the treatment.
Assumption 6 (Staggered adoption designs) For all g and t ≥ 2, Dg,t ≥ Dg,t−1.
For any g ∈ {1, ..., G}, let Fg = min{t : Dg,t = 1} denote the first date at which group g is
treated, with the convention that Fg = T + 1 if group g is never treated.
Our parameters of interest are motivated by a welfare analysis. The treatment Dg,t may for
instance correspond to a policy that is costly to implement, and a planner may seek to compare
the welfare gains produced by the policy to its cost (see Manski, 2005). We assume that for any
possible value dt of the treatments up to period t, the average utility in group g at period t is
equal to Yg,t(dt)+Ug,t. If the social planner wants to compare the population’s expected average
intertemporal utility under the actual treatments received by all groups and under the scenario
where all groups are never treated, then she would like to learn
δATT = E
 ∑
g:Fg≤T
T∑
t=Fg
Ng,t
ND
βt(Yg,t(Dg,t)− Yg,t(0t))
 ,
where β is the planner’s discount factor, and ND =
∑
g:Fg≤T
∑T
t=Fg
Ng,t is the number of units in
the treated (g, t) cells. With β = 1 and assuming no dynamic effects (Yg,t(d1, ..., dt) = Yg,t(dt)),
δATT is equal to the standard average treatment effect on the treated (ATT) parameter. Thus,
δATT generalizes the ATT to settings with dynamic treatment effects, and it allows for the
possibility that the planner may discount later periods relative to earlier ones.
If the social planner wants to compare the population’s utility under the actual treatments
received and under the scenario where all groups keep the same treatment as in the first period
(the status quo scenario), then she would like to learn
δSQ = E
 ∑
g:2≤Fg≤T
T∑
t=Fg
Ng,t
NS
βt(Yg,t(Dg,t)− Yg,t(0t))
 ,
6
where NS =
∑
g:2≤Fg≤T
∑T
t=Fg
Ng,t is the number of units in the treated (g, t) cells, excluding the
always treated groups. If there are no always treated groups (Fg > 1 for all g), δATT = δSQ. If
there are always treated groups, not taking their treatment effect into account may be justified,
if the planner wants to evaluate the welfare effects of the policy decisions that took place over
the period under consideration, and not of earlier policy decisions.
Before proposing an estimator of δSQ, we consider parameters that are simpler to estimate. For
any ` ∈ {0, ..., T − 2}, let N` =
∑
g:2≤Fg≤T−`Ng,Fg+` denote the number of units in the (g, t) cells
such that at period t, group g has started receiving the treatment ` periods ago. Let
∆` =
∑
g:2≤Fg≤T−`
Ng,Fg+l
N`
βFg+`(Yg,Fg+`(Dg,Fg+`)− Yg,Fg+`(0Fg+`)) (1)
if N` > 0, and let ∆` = 0 otherwise. If β = 1, ∆` is just the average effect of having been
treated for ` periods, across all the groups treated for ` periods before period T , and excluding
the always treated groups. If β < 1, ∆` has the same interpretation, except that groups’
treatment effect is discounted according to the date when they reach ` periods of treatment. Let
L = T − ming:Fg≥2 Fg denote the number of time periods between the earliest date at which a
group goes from untreated to treated and date T . N` = 0 if and only if ` > L: if ` > L, the
effect of being treated for ` periods is not observed for any group. Finally, let δ` = E (∆`).
For any ` ∈ {0, ..., T − 2} and t ∈ {`+ 2, ..., T}, let N `t =
∑
g:Fg=t−`Ng,t and N
0
t =
∑
g:Fg>t
Ng,t.
Let
DIDt,` = βt
 ∑
g:Fg=t−`
Ng,t
N `t
(Yg,t − Yg,t−`−1)−
∑
g:Fg>t
Ng,t
N0t
(Yg,t − Yg,t−`−1)

if N `t > 0 and N0t > 0, and let DIDt,` = 0 otherwise. DIDt,` is the βt-discounted DID estimator
comparing the outcome evolution from period t − ` − 1 to t in groups that became treated in
t− ` and in groups still untreated in t. Under Assumptions 4-5, the expectation of the outcome
evolution in the latter set of groups is a counterfactual of the evolution that would have taken
place in the former set of groups if it had not started receiving the treatment ` periods ago.
Thus, DIDt,` is an unbiased estimator of the effect of having been treated for ` periods in those
groups. Then, let NDID` =
∑
t≥`+2,N0t >0N
`
t be the number of units in (g, t) cells such that group
g has been treated for ` periods at date t, and another group is untreated at t. Let
DID` =
T∑
t=`+2
N `t
NDID`
DIDt,`
if NDID` > 0, and let DID` = 0 otherwise. DID` is our estimator of δ`. Under Assumption
6, DID0 with β = 1 is equal to the DIDM estimator in de Chaisemartin and D’Haultfœuille
(2020).The DID` estimators with β = 1 are computed by the Stata did_multiplegt package.
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We have the following relationship between δSQ and the (∆`)0≤`≤L:
E
(
L∑
`=0
N`
NS
∆`
)
=E
 L∑
`=0
∑
g:2≤Fg≤T−`
Ng,Fg+`
NS
βFg+`(Yg,Fg+`(Dg,Fg+`)− Yg,Fg+`(0Fg+`))

=E
 ∑
g:2≤Fg≤T
T−Fg∑
`=0
Ng,Fg+`
NS
βFg+`(Yg,Fg+`(Dg,Fg+`)− Yg,Fg+`(0Fg+`))

=δSQ. (2)
Accordingly, we estimate δSQ by
δ̂SQ =
L∑
`=0
NDID`
NS
DID`.
The following theorem gives conditions under which DID` and δ̂SQ are unbiased estimators of δ`
and δSQ.
Theorem 1 Suppose that Assumptions 1-6 hold and NS > 0.
1. For any ` ∈ {0, ..., T − 2}, if maxg∈{1,...,G} Fg > maxg:2≤Fg≤T−` Fg + `, E [DID`] = δ`.
2. If maxg∈{1,...,G} Fg = T + 1, E
[
δ̂SQ
]
= δSQ.
The condition maxg∈{1,...,G} Fg > maxg:2≤Fg≤T−` Fg + ` requires that at the last time period when
a group reaches ` periods of treatment, there is still at least one untreated group. This condition
can be tested from the data. Point 1 of Theorem 1 shows that under this condition, the average
effect of having been treated for ` periods δ` can be unbiasedly estimated. Then, Point 2 of the
theorem shows that δSQ can also be unbiasedly estimated, provided there is at least one group
that is still untreated at date T . When no group is treated at the start of the panel, δSQ and
δATT are equal, so δATT can also be unbiasedly estimated.
Theorem 1 applies to designs where at least one group is still untreated at the end of the panel.
We now consider cases where that condition is not met. Let NT = maxg∈{1,...,G} Fg − 1 denote
the last period where at least one group is still untreated. Let N trunS =
∑
g:2≤Fg≤NT
∑NT
t=Fg
Ng,t
be the number of units in the (g, t) cells that are treated and such that t ≤ NT , excluding the
always treated groups. Let
δtrunSQ = E
 ∑
g:2≤Fg≤NT
NT∑
t=Fg
Ng,t
N trunS
βt(Yg,t(Dg,t)− Yg,t(0t))

denote the truncated-at-NT version of δSQ, that only takes into account the treatment effects
until period NT . For any ` ∈ {0, ..., T−2}, let N trun` =
∑
g:2≤Fg≤NT−`Ng,Fg+` denote the number
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of units in (g, t) cells such that at period t, group g has started receiving the treatment ` periods
ago and there is still an untreated group, excluding the always treated groups. Let
∆trun` =
∑
g:2≤Fg≤NT−`
Ng,Fg+l
N trun`
βFg+`(Yg,Fg+`(Dg,Fg+`)− Yg,Fg+`(0Fg+`))
if N trun` > 0, and let ∆trun` = 0 otherwise. ∆trun` is the truncated-at-NT version of ∆`, the effect
of being treated for ` periods. Let δtrun` denote its expectation. Using the same steps as those
use to prove Equation (2), one can show that
E
(
L∑
`=0
N trun`
N trunS
∆trun`
)
=δtrunSQ . (3)
Then, we let δ̂trunSQ =
∑L
`=0(NDID`/N
trun
S )DID`. The δ̂trunSQ estimator with β = 1 is computed by
the Stata did_multiplegt package.
Theorem 2 Suppose that Assumptions 1-6 hold and N trunS > 0.
1. For any ` ∈ {0, ..., T − 2}, E [DID`] = δtrun` .
2. E
[
δ̂trunSQ
]
= δtrunSQ .
Theorem 2 shows that δtrunSQ can be unbiasedly estimated even when there is no untreated group
at period T . However, unlike δSQ, it is harder to rationalize why a social planner would want to
learn δtrunSQ . The treatment effects in δtrunSQ are a subset of those in δSQ. Accordingly, we propose
to use
λtrun =
∑
g:2≤Fg≤NT
∑NT
t=Fg
Ng,tβ
t∑
g:2≤Fg≤T
∑T
t=Fg
Ng,tβt
,
a quantity that can be computed from the data, to assess whether δtrunSQ is an “interesting”
parameter. When that ratio is close to 1, most of the treatment effects in δSQ are also in δtrunSQ ,
so δtrunSQ may be useful for social choice. When potential outcomes are bounded, one can estimate
bounds for δSQ based on Theorem 2 and λtrun. Notice that if β = 1, λtrun = N trunS /NS.
4 Results in general designs
4.1 Results without ruling out dynamic effects beyond any lag
In this section we no longer assume that treatments follow a staggered adoption design. Groups
may switch in or out of the treatment at any date. For every g ∈ {1, ..., G}, let Sg = min{t ≥ 2 :
Dg,t 6= Dg,t−1} denote the first date at which group g’s treatment changes, with the convention
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that Sg = T + 1 if group g’s treatment never changes. For all t, let 1t denote a 1 × t vector of
ones. Hereafter, we refer to Yg,t(1t), the potential outcome that group g will obtain at period t
if she remains treated from period 1 to t, as the always-treated potential outcome.
Again, our parameters of interest are motivated by a welfare analysis. In groups untreated at
period 1, a planner interested in evaluating the welfare effects of the policy changes that took
place from period 1 to T wants to compare the actual outcome to the never-treated outcome,
the outcome that would have been realized without any policy change. This leads us to consider
the following parameter:
δSQ,0 = E
 ∑
g:Sg≤T
(1−Dg,1)
T∑
t=Sg
Ng,t
NS,0
βt(Yg,t(Dg,t)− Yg,t(0t))
 ,
where NS,0 =
∑
g:Sg≤T (1 − Dg,1)
∑T
t=Sg
Ng,t is the number of units in the (g, t) cells such that
group g was untreated at period 1 and her treatment has changed for the first time at or before
t. Under Assumption 6, δSQ,0 is equal to δSQ in the previous section, so δSQ,0 is a generalization
of δSQ to non-staggered designs.
In groups treated at period 1, the planner wants to compare the actual outcome to the always-
treated outcome, the outcome that would have been realized without any policy change. This
leads us to consider the following parameter:
δSQ,1 = E
 ∑
g:Sg≤T
Dg,1
T∑
t=Sg
Ng,t
NS,1
βt(Yg,t(Dg,t)− Yg,t(1t))
 ,
where NS,1 =
∑
g:Sg≤T Dg,1
∑T
t=Sg
Ng,t is the number of units in the (g, t) cells such that group
g was treated at period 1 and her treatment has changed for the first time at or before t.
Finally, the planner may be interested in aggregating those two parameters, to perform a cost-
benefit analysis of all the policy changes that occurred over the period. This leads us to consider
the following parameter:
δCB =
NS,0
NS
δSQ,0 − NS,1
NS
δSQ,1,
where NS = NS,0 +NS,1. δSQ,1 enters with a negative sign, because it is the effect of a reduction
in exposure to the treatment, while δSQ,0 is the effect of an increase. When aggregating them,
the two parameters have to be put on the same scale.
As in the previous section, we cannot unbiasedly estimate δSQ,0, δSQ,1 and δCB in general, so we
consider hereafter their truncated versions. Let NT = maxg:Dg,1=0 Sg − 1 denote the last period
at which at least one group has never been treated, and let AT = maxg:Dg,1=1 Sg − 1 denote the
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last period at which at least one group has always been treated. Then, let
δtrunSQ,0 =E
 ∑
g:Sg≤NT
(1−Dg,1)
NT∑
t=Sg
Ng,t
N trunS,0
βt(Yg,t(Dg,t)− Yg,t(0t))
 ,
δtrunSQ,1 =E
 ∑
g:Sg≤AT
Dg,1
AT∑
t=Sg
Ng,t
N trunS,1
βt(Yg,t(Dg,t)− Yg,t(1t))
 ,
δtrunCB =
N trunS,0
N trunS
δtrunSQ,0 −
N trunS,1
N trunS
δtrunSQ,1,
where
N trunS,0 =
∑
g:Sg≤NT
(1−Dg,1)
NT∑
t=Sg
Ng,t,
N trunS,1 =
∑
g:Sg≤AT
Dg,1
AT∑
t=Sg
Ng,t,
N trunS =N
trun
S,0 +N
trun
S,1 .
δtrunSQ,0 (resp. δtrunSQ,1) is a version of δSQ,0 (resp. δSQ,1) truncated at NT (resp. AT ). Similarly,
δtrunCB is a truncated version of δCB. As in the previous section, let
λtrun =
∑
g:Sg≤NT (1−Dg,1)
∑NT
t=Sg
Ng,tβ
t +
∑
g:Sg≤AT Dg,1
∑AT
t=Sg
Ng,tβ
t∑
g:Sg≤T (1−Dg,1)
∑T
t=Sg
Ng,tβt +
∑
g:Sg≤T Dg,1
∑T
t=Sg
Ng,tβt
denote the “ ‘proportion” of δCB’s treatment effects that are also in δtrunCB .
δtrunSQ,0 can be unbiasedly estimated under the same assumptions as in the previous section. On
the other hand, new assumptions are needed to unbiasedly estimate δtrunSQ,1.
Assumption 7 (Strong exogeneity for the always treated outcome) ∀t ≥ 2, E(Yg,t(1t)−Yg,t−1(1t−1)|Dg) =
E(Yg,t(1t)− Yg,t−1(1t−1)).
Assumption 7 is the equivalent of Assumption 4, for the always-treated potential outcome.
It requires that the shocks affecting a group’s Yg,t(1t) be mean independent of that group’s
treatment sequence.
Assumption 8 (Common trends for the always treated outcome) ∀t ≥ 2, E(Yg,t(1t)−Yg,t−1(1t−1))
does not vary across g.
Again, Assumption 8 is the equivalent of Assumption 5, for the always-treated potential outcome.
It requires that between each pair of consecutive periods, the expectation of the always-treated
outcome follow the same evolution over time in every group.
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For any ` ∈ {0, ..., T − 2} and t ∈ {`+ 2, ..., T}, let
N `,+t =
∑
g:Sg=t−`
(1−Dg,1)Ng,t,
N `,−t =
∑
g:Sg=t−`
Dg,1Ng,t,
N0t =
∑
g:Sg>t
(1−Dg,1)Ng,t,
N1t =
∑
g:Sg>t
Dg,1Ng,t.
Let
DID+t,` = β
t
 ∑
g:Sg=t−`
(1−Dg,1) Ng,t
N `,+t
(Yg,t − Yg,t−`−1)−
∑
g:Sg>t
(1−Dg,1)Ng,t
N0t
(Yg,t − Yg,t−`−1)

if N `,+t > 0 and N0t > 0, and let DID
+
t,` = 0 otherwise. DID
+
t,` is the βt-discounted DID estimator
comparing the outcome evolution from period t− `− 1 to t in groups untreated in period 1 and
whose treatment changed for the first time in t−` and in groups untreated in period 1 and whose
treatment has not changed yet in t. Under Assumptions 4-5, the expectation of the outcome
evolution in the latter set of groups is a counterfactual of the evolution that would have taken
place in the former set of groups if it had remained untreated till t. Thus, DID+t,` is an unbiased
estimator of the effect of not having remained untreated till t in those groups.
Let
DID−t,` = β
t
 ∑
g:Sg=t−`
Dg,1
Ng,t
N `,−t
(Yg,t − Yg,t−`−1)−
∑
g:Sg>t
Dg,1
Ng,t
N1t
(Yg,t − Yg,t−`−1)

if N `,−t > 0 and N1t > 0, and let DID
−
t,` = 0 otherwise. DID
−
t,` is the βt-discounted DID estimator
comparing the outcome evolution from period t − ` − 1 to t in groups treated in period 1 and
whose treatment changed for the first time in t− ` and in groups treated in period 1 and whose
treatment has not changed yet in t. Under Assumptions 7-8, DID−t,` is an unbiased estimator of
the effect of not having remained treated till t in the former groups.
Then, let
NDID+`
=
∑
t≥`+2,N0t >0
N `,+t
NDID−`
=
∑
t≥`+2,N1t >0
N `,−t .
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Finally, let
DID+` =
T∑
t=`+2
N `,+t
NDID+`
DID+t,`
if NDID+` > 0 and let DID
+
` = 0 otherwise, and let
DID−` =
T∑
t=`+2
N `,−t
NDID−`
DID−t,`
if NDID−` > 0 and let DID
−
` = 0 otherwise. Under Assumption 6, DID
+
` is equal to DID` in the
previous section. Finally, we let
δ̂trunSQ,0 =
L∑
`=0
NDID+`
N trunS,0
DID+` ,
δ̂trunSQ,1 =
L∑
`=0
NDID−`
N trunS,1
DID−` ,
δ̂trunCB =
N trunS,0
N trunS
δ̂trunSQ,0 −
N trunS,1
N trunS
δ̂trunSQ,1.
Theorem 3 Suppose that Assumptions 1-3 hold.
1. If Assumptions 4 and 5 also hold, E
[
δ̂trunSQ,0
]
= δtrunSQ,0.
2. If Assumptions 7 and 8 also hold, E
[
δ̂trunSQ,1
]
= δtrunSQ,1.
3. If Assumptions 4-5 and 7-8 also hold, E
[
δ̂trunCB
]
= δtrunCB .
If there is at least one group untreated from period 1 to T , δtrunSQ,0 = δSQ,0, so Point 1 of Theorem
3 implies that δSQ,0 can be unbiasedly estimated. Similarly, if there is at least one group treated
from period 1 to T , δtrunSQ,1 = δSQ,1, so Point 2 of Theorem 3 implies that δSQ,1 can be unbiasedly
estimated. Accordingly, if there is both a never treated and an always treated group, δCB, the
parameter the planner needs to know to evaluate the policy changes that took place during the
period under consideration, can also be unbiasedly estimated. If there is no never-treated or no
always-treated group, δCB can no longer be unbiasedly estimated, but one can still unbiasedly
estimate δtrunCB , whose closedness to δCB can be assessed by computing λtrun. Whether λtrun is
close to 1 or not depends on whether NT (resp. AT ), the number of periods for which at least
one group remains untreated (resp. treated) is close to T or not. Accordingly, δtrunCB and δCB
should be close in short panels, or in instances where groups rarely change treatment.
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4.2 Results ruling out dynamic effects beyond a certain lag
On the other hand, λtrun may be low in long panels, and in instances where groups often change
treatment. Then, δtrunCB may be very different from δCB. We now consider an assumption on
dynamic treatment effects indexed by k ∈ {0, ..., T − 1}. If this assumption is plausible for some
k, one may be able to unbiasedly estimate a parameter close to that the planner needs to know
for policy evaluation.
Assumption 9-k (Treatments from up to k-periods ago can affect the current outcome)
For all g, all t ≥ k + 1, and all (d1, ..., dt) ∈ {0, 1}t, Yg,t(d1, ..., dt) = Yg,t(dt−k, ..., dt).
Assumption 9-k is equivalent to ruling out dynamic effects beyond the kth-lagged treatment, an
assumption often implicitly made in event-study regressions (see Autor, 2003). For instance, if
k = 1, only the period-t and period-t−1 treatments can affect the period t-outcome. Assumption
9-k is plausible in instances where the treatment is unlikely to have very long-run effects.
Under Assumption 9-k, if a group’s treatment changes at some point, this change may have an
effect for at most k periods thereafter. Accordingly, in her cost-benefit analysis, the planner
only needs to take into account the effect of that change at the period it takes place and the k
following periods, relative to the scenario where that change had not taken place. This motivates
the following generalization of the δCB parameter introduced in the previous subsection. For all
g, t ≥ 2, and k ≥ 0, let Sg,t,k = min{t′ ∈ {max(t−k, 2), ..., t} : Dg,t′ 6= Dg,t′−1} be the least recent
date included between t−k and t (or 2 and t if t−k < 2) at which group g’s treatment changed.
We let Sg,t,k = 0 if group g’s treatment did not change treatment between max(t− k, 2)− 1 and
t, or if t = 1. Let NS,k =
∑
(g,t):Sg,t,k≥2Ng,t denote the number of units in the (g, t) cells such
that g’s treatment changed at least once over the k periods before t. Finally, let
δCB,k =E
 ∑
(g,t):Sg,t,k≥2
(1−Dg,Sg,t,k−1)
Ng,t
NS,k
βt(Yg,t(Dg,max(t−k,1), ..., Dg,t)− Yg,t(0min(t,k+1))
−Dg,Sg,t,k−1
∑
(g,t):Sg,t,k≥2
Ng,t
NS,k
βt(Yg,t(Dg,max(t−k,1), ..., Dg,t)− Yg,t(1min(t,k+1)))
 .
δCB,k is a discounted weighted average of the effect of having changed treatment, in all the (g, t)
cells such that g’s treatment changed at least once over the last k periods before t. Remarking
that Sg,t,T−1 = Sg1{t ≥ Sg}, one can show that δCB,T−1 is equal to δCB in the previous subsection.
Also, δCB,0 with β = 1 is equal to the average treatment effect among the switchers considered
by de Chaisemartin and D’Haultfœuille (2020).
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As in the previous sections, we cannot unbiasedly estimate δCB,k in general, so we consider a
truncated version of it. Let
Cg,t,k =Sg,t,k × 1
{
Sg,Sg,t,k−1,k−1 = 0,∃g′ ∈ {1, ..., G} : Sg′,t,k = Sg′,Sg,t,k−1,k−1 = 0,
Dg′,Sg,t,k−1 = Dg,Sg,t,k−1
}
.
Thus, Cg,t,k 6= 0 (and then Cg,t,k ≥ 2) under the following conditions. First, g’s treatment has
changed at least once over the k periods before t (so that Sg,t,k > 0) and did not change for at
least k−1 periods before that change (so that Sg,Sg,t,k−1,k−1 = 0). Second, at least another group
g′ had the same treatment as g before g’s treatment changed (Dg′,Sg,t,k−1 = Dg,Sg,t,k−1) and did
not experience any change in its treatment from the k−1th period before g’s treatment changed
until period t (Sg′,t,k = Sg′,Sg,t,k−1,k−1 = 0). Under Assumptions 4, 5, 7, 8, and 9-k, g′ can act as
a control to infer the outcome evolution g would have experienced until period t if her treatment
had not changed. Let N trunS,k =
∑
(g,t):Cg,t,k≥2Ng,t denote the number of units in the (g, t) cells
such that g’s treatment changed at least once over the k periods before t, and there is at least
another group g′ that can act as a control for g. Finally, let
δtrunCB,k =E
 ∑
(g,t):Cg,t,k≥2
(1−Dg,Sg,t,k−1)
Ng,t
N trunS,k
βt(Yg,t(Dg,max(t−k,1), ..., Dg,t)− Yg,t(0min(t,k+1))
−Dg,Sg,t,k−1
∑
(g,t):Cg,t,k≥2
Ng,t
N trunS,k
βt(Yg,t(Dg,max(t−k,1), ..., Dg,t)− Yg,t(1min(t,k+1)))
 .
δtrunCB,k is a version of δCB,k truncated from the treatment effect in all the (g, t) cells such that g’s
treatment changed at least once over the k periods before t but there is no other group g′ that
can act as a control to estimate the effect of that change. As previously, let
λtrunk =
∑
(g,t):Cg,t,k≥2Ng,tβ
t∑
(g,t):Sg,t,k≥2Ng,tβ
t
denote the “ ‘proportion” of δCB,k’s treatment effects that are also in δtrunCB,k.
δtrunCB,T−1 = δ
trun
CB , so if k = T − 1, the estimators we propose are the same as in the previous
subsection. We therefore assume that k ≤ T − 2. For any ` ∈ {0, ..., k} and t ∈ {`+ 2, ..., T}, let
N `,+t =
∑
g:Sg,t,k=t−`,Sg,t−`−1,k−1=0
(1−Dg,t−`−1)Ng,t
N `,−t =
∑
g:Sg,t,k=t−`,Sg,t−`−1,k−1=0
Dg,t−`−1Ng,t
N `,0t =
∑
g:Sg,t,k=0,Sg,t−`−1,k−1=0
(1−Dg,t−`−1)Ng,t
N `,1t =
∑
g:Sg,t,k=0,Sg,t−`−1,k−1=0
Dg,t−`−1Ng,t.
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Let
DID+t,` =β
t
 ∑
g:Sg,t,k=t−`,Sg,t−`−1,k−1=0
(1−Dg,t−`−1) Ng,t
N `,+t
(Yg,t − Yg,t−`−1)
−
∑
g:Sg,t,k=0,Sg,t−`−1,k−1=0
(1−Dg,t−`−1)Ng,t
N `,0t
(Yg,t − Yg,t−`−1)

if N `,+t > 0 and N
`,0
t > 0, and let DID
+
t,` = 0 otherwise. DID
+
t,` is the βt-discounted DID
estimator comparing the outcome evolution from period t− `− 1 to t in groups untreated from
period t− `− 1− k to t− `− 1 and treated in t− ` to the same evolution in groups untreated
from period t− `− 1− k to t. Under Assumptions 4-5 and 9-k, the expectation of the outcome
evolution in the latter set of groups is a counterfactual of the evolution that would have taken
place in the former set of groups if it had remained untreated till t. Thus, DID+t,` is an unbiased
estimator of the effect of not having remained untreated till t in those groups. Let
DID−t,` =β
t
 ∑
g:Sg,t,k=t−`,Sg,t−`−1,k−1=0
Dg,t−`−1
Ng,t
N `,−t
(Yg,t − Yg,t−`−1)
−
∑
g:Sg,t,k=0,Sg,t−`−1,k−1=0
Dg,t−`−1
Ng,t
N `,1t
(Yg,t − Yg,t−`−1)

if N `,−t > 0 and N
`,1
t > 0, and let DID
−
t,` = 0 otherwise. DID
−
t,` is the βt-discounted DID
estimator comparing the outcome evolution from period t − ` − 1 to t in groups treated from
period t− `− 1− k to t− `− 1 and untreated in t− ` to the same evolution in groups treated
from period t− `− 1− k to t. Under Assumptions 7-8 and 9-k, DID−t,` is an unbiased estimator
of the effect of not having remained treated till t in the former set of groups.
Then, let NDID` =
∑
t≥`+2,N`,0t >0N
`,+
t +
∑
t≥`+2,N`,1t >0N
`,−
t . Let
DID` =
T∑
t=`+2
(
N `,+t
NDID`
DID+t,` −
N `,−t
NDID`
DID−t,`
)
if NDID` > 0, and let DID` = 0 otherwise. For k = 0 and β = 1, DID0 is equal to the DIDM esti-
mator in de Chaisemartin and D’Haultfœuille (2020). Finally, let δ̂trunCB,k =
∑k
`=0(NDID`/N
trun
S,k )DID`.
Theorem 4 Suppose that Assumptions 2-5, 7, 8, and 9-k hold and N trunS,k > 0. Then,
E
[
δ̂trunCB,k
]
= δtrunCB,k.
Suppose Assumption 9-0 is plausible. If for all (g, t) such that t ≥ 2 and Dg,t 6= Dg,t−1, there is
another g′ such that Dg′,t = Dg′,t−1 = Dg,t−1, then δtrunCB,0 = δCB,0. Therefore, Theorem 4 implies
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that the parameter the planner needs to know to evaluate the policy changes that took place
over the period can be unbiasedly estimated. Note also that in this case, with k = 0 and β = 1
Theorem 4 is equivalent to Theorem 3 in de Chaisemartin and D’Haultfœuille (2020).
Now, suppose Assumption 9-0 is implausible, but Assumption 9-1 is. Moreover, assume that the
following two conditions hold:
1. for all t ≥ 3, all (g, t) such that Dg,t 6= Dg,t−1 are also such that Dg,t−1 = Dg,t−2 and there
is another g′ such that Dg′,t+1 = Dg′,t = Dg′,t−1 = Dg′,t−2 = Dg,t−2
2. for all g such that Dg,2 6= Dg,1, there is another g′ such that Dg′,2 = Dg′,1 = Dg,1.
Then δtrunCB,1 = δCB,1, and Theorem 4 implies that δCB,1 can be unbiasedly estimated. Notice that
the conditions under which δtrunCB,1 = δCB,1 are stronger than those under which δtrunCB,0 = δCB,0.
Therefore, it is more likely that only the truncated parameter can be unbiasedly estimated when
one works under Assumption 9-1, than when one works under Assumption 9-0. Similarly, when
only the truncated parameter can be estimated in both cases, that parameter should be closer
to the untruncated one under Assumption 9-0 than under Assumption 9-1 (λtrun1 < λtrun0 ). The
same conclusion applies to higher values of k: one should typically have that k 7→ λtrunk is
decreasing. Then, there is a trade-off between the plausibility of the assumptions one imposes,
and the relevance of the parameter that can be estimated under those assumptions.
Finally, as discussed previously some groups may have already been treated prior to period 1,
and those treatments may still affect some of their period-1-to-T outcomes. However, under
Assumption 9-k, one can circumvent this problem, by redefining the DID` estimators above by
considering only time periods after k + 1.
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A Appendix: proofs
A.1 Proofs of Theorems 1 and 2
Let D = (Dg)g=1,...,G. We first prove the following lemma.
Lemma 1 If Assumptions 2-6 hold, then for any ` ∈ {0, ..., T − 2} E [DID`|D] = E [∆trun` |D] .
Proof: DID`1{L < `} = ∆trun` 1{L < `} = 0, so to prove the result, it is sufficient to show that
1{L ≥ `}E [DID`|D] = 1{L ≥ `}E [∆`|D] .
We consider an arbitrary ` ∈ {0, ..., L}. By Assumption 5, for all t ≥ 2 there is a real number
ψt such that ψt = E(Yg,t(0t)− Yg,t−1(0t−1)) for all g. Then, for all g and all t ≥ `+ 2,
E[Yg,t(0t)− Yg,t−`−1(0t−`−1)] =
∑`
k=0
ψt−k. (4)
Then, for all t ∈ {`+ 2, ..., T} such that N `t > 0 and N0t > 0,
1{L ≥ `}E[DIDt,`|D]
=1{L ≥ `}βt
 ∑
g:Fg=t−`
Ng,t
N `t
E[Yg,t − Yg,t−`−1|D]−
∑
g:Fg>t
Ng,t
N0t
E[Yg,t − Yg,t−`−1|D]

=1{L ≥ `}βt
 ∑
g:Fg=t−`
Ng,t
N `t
E [Yg,t(Dg,t)− Yg,t(0t)|D]
+
∑
g:Fg=t−`
Ng,t
N `t
E [Yg,t(0t)− Yg,t−`−1(0t−`−1)|D]−
∑
g:Fg>t
Ng,t
N0t
E[Yg,t(0t)− Yg,t−`−1(0t−`−1)|D]

=1{L ≥ `}βt
 ∑
g:Fg=t−`
Ng,t
N `t
E [Yg,t(Dg,t)− Yg,t(0t)|D]
+
∑
g:Fg=t−`
Ng,t
N `t
E [Yg,t(0t)− Yg,t−`−1(0t−`−1)]−
∑
g:Fg>t
Ng,t
N0t
E[Yg,t(0t)− Yg,t−`−1(0t−`−1)]

=1{L ≥ `}βtE
 ∑
g:Fg=t−`
Ng,t
N `t
(Yg,t(Dg,t)− Yg,t(0t))
∣∣∣∣∣∣D
 . (5)
The first equality holds by the definition of DIDt,` and the fact that N `t > 0 and N0t > 0. The
second equality holds by Assumptions 3 and 6. The third equality follows from Assumptions 2
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and 4. The last equality follows from Equation (4). Then,
1{L ≥ `}E[DID`|D]
=1{L ≥ `,NDID` > 0}
(
T∑
t=`+2
N `t
NDID`
E[DIDt,`|D]
)
=1{L ≥ `,NDID` > 0}
 NT∑
t=`+2
βtE
 ∑
g:Fg=t−`
Ng,t
N trun`
(Yg,t(Dg,t)− Yg,t(0t))
∣∣∣∣∣∣D

=1{L ≥ `,NDID` > 0}E
[
∆trun` |D
]
=1{L ≥ `}E [∆trun` |D] .
The first equality follows from the definition of DID`. The second equality follows from the
following facts. First, DIDt,` = 0 for t > NT . Second, if t ≤ NT , we have N0t > 0 and thus
Equation (5) holds if N `t > 0. Third, if N `t = 0, we have
∑
g:Fg=t−`Ng,t(Yg,t(Dg,t) − Yg,t(0t)) =
DIDt,` = 0. Finally, we use N trun` = NDID` . The last equality follows from N trun` = NDID` , and
∆trun` = 0 if N trun` = 0 
Turning to Theorem 2, Point 1 follows from Lemma 1 and the law of iterated expectations.
Point 2 follows from NDID` = N trun` , Lemma 1, the law of iterated expectations and (3).
Finally, we prove Theorem 1. Point 1 follows from Point 1 of Theorem 2, and the fact that
maxg∈{1,...,G} Fg > maxg:2≤Fg≤T−` Fg + ` implies that δtrun` = δ`. Point 2 follows from Point 2 of
Theorem 2, and the fact that maxg∈{1,...,G} Fg = T + 1 implies that δtrunSQ = δSQ.
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A.2 Proof of Theorem 3
First, note that for any ` ∈ {0, ..., T − 2} and t ∈ {`+ 2, ..., T} such that N `,+t > 0 and N0t > 0,
E
(
DID+t,`|D
)
=βt
 ∑
g:Sg=t−`
(1−Dg,1) Ng,t
N `,+t
E (Yg,t − Yg,t−`−1|D)−
∑
g:Sg>t
(1−Dg,1)Ng,t
N0t
E (Yg,t − Yg,t−`−1|D)

=βt
 ∑
g:Sg=t−`
(1−Dg,1) Ng,t
N `,+t
E (Yg,t(Dg,t)− Yg,t(0t)|D)
+
∑
g:Sg=t−`
(1−Dg,1) Ng,t
N `,+t
E (Yg,t(0t)− Yg,t−`−1(0t−`−1)|D)
−
∑
g:Sg>t
(1−Dg,1)Ng,t
N0t
E (Yg,t(0t)− Yg,t−`−1(0t−`−1)|D)

=βt
∑
g:Sg=t−`
(1−Dg,1) Ng,t
N `,+t
E (Yg,t(Dg,t)− Yg,t(0t)|D) . (6)
The first equality follows from the definition of DID+t,`, N
`,+
t > 0 and N0t > 0. The second
equality follows from Assumption 3. The third equality follows from Assumptions 2 and 4 and
Equation (4). Then,
L∑
`=0
NDID+`
N trunS,0
E
(
DID+` |D
)
=
L∑
`=0
T∑
t=`+2
N `,+t
N trunS,0
E
(
DID+t,`|D
)
=
L∑
`=0
NT∑
t=`+2
βt
∑
g:Sg=t−`
(1−Dg,1) Ng,t
N trunS,0
E (Yg,t(Dg,t)− Yg,t(0t)|D)
=
∑
g:Sg≤NT
(1−Dg,1)
NT∑
t=Sg
βt
Ng,t
N trunS,0
E (Yg,t(Dg,t)− Yg,t(0t)|D) . (7)
The first equality follows from the definition of DID+` , and from the fact DID
+
t,` = 0 for all
t ∈ {` + 2, ..., T} if NDID+` = 0. The second equality follows from the following facts. First, if
t > NT , DID+t,` = 0. Second, if t ≤ NT , N0t > 0 by definition of NT . Then we use Equation
(6) if N `,+t > 0, and if N
`,+
t = 0,
DID+t,` =
∑
g:Sg=t−`
(1−Dg,1) Ng,t
N trunS,0
E (Yg,t(Dg,t)− Yg,t(0t)|D) = 0.
Then Point 1 follows from Equation (7) and the law of iterated expectations. Point 2 follows
from the same reasoning, using Assumptions 7 and 8 instead of Assumptions 4 and 5. Point 3
follows directly from Points 1 and 2.
21
A.3 Proof of Theorem 4
Under Assumption 9-k, it follows from Equation (4) that for all g, all ` ≥ 0 and all t ≥ `+ 2,
E[Yg,t(0min(t,k+1))− Yg,t−`−1(0min(t−`−1,k+1))] =
∑`
j=0
ψt−j. (8)
For any ` ∈ {0, ..., k} and t ∈ {`+ 2, ..., T} such that N `,+t > 0 and N `,0t > 0,
E
(
DID+t,`|D
)
=βt
 ∑
g:Sg,t,k=t−`,
Sg,t−`−1,k−1=0
(1−Dg,t−`−1) Ng,t
N `,+t
E (Yg,t − Yg,t−`−1|D)
−
∑
g:Sg,t,k=0,
Sg,t−`−1,k−1=0
(1−Dg,t−`−1)Ng,t
N `,0t
E (Yg,t − Yg,t−`−1|D)

=βt
 ∑
g:Sg,t,k=t−`,
Sg,t−`−1,k−1=0
(1−Dg,t−`−1) Ng,t
N `,+t
E
(
Yg,t(Dg,max(t−k,1), ..., Dg,t)− Yg,t(0min(t,k+1))|D
)
+
∑
g:Sg,t,k=t−`,
Sg,t−`−1,k−1=0
(1−Dg,t−`−1) Ng,t
N `,+t
E
(
Yg,t(0min(t,k+1))− Yg,t−`−1(0min(t−`−1,k+1))|D
)
−
∑
g:Sg,t,k=0,
Sg,t−`−1,k−1=0
(1−Dg,t−`−1)Ng,t
N `,0t
E
(
Yg,t(0min(t,k+1))− Yg,t−`−1(0min(t−`−1,k+1))|D
)
=βt
∑
g:Sg,t,k=t−`,
Sg,t−`−1,k−1=0
(1−Dg,t−`−1) Ng,t
N `,+t
E
(
Yg,t(Dg,max(t−k,1), ..., Dg,t)− Yg,t(0min(t,k+1))|D
)
. (9)
The first equality follows from the definition of DID+t,` and N
`,+
t > 0 and N
`,0
t > 0. The second
equality follows from Assumptions 3 and 9-k and the definitions of Sg,t,k and Sg,t−`−1,k−1. The
third equality follows from Assumptions 2 and 4 and Equation (8).
Similarly, one can show that for any ` ∈ {0, ..., k} and t ∈ {`+ 2, ..., T} such that N `,−t > 0 and
N `,1t > 0,
E
(
DID−t,`|D
)
=βt
∑
g:Sg,t,k=t−`,
Sg,t−`−1,k−1=0
Dg,t−`−1
Ng,t
N `,−t
E
(
Yg,t(Dg,max(t−k,1), ..., Dg,t)− Yg,t(1min(t,k+1))|D
)
. (10)
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Finally,
k∑
`=0
NDID`
N trunS,k
E (DID`|D)
=
k∑
`=0
T∑
t=`+2
(
N `,+t
N trunS,k
E
(
DID+t,`|D
)− N `,−t
N trunS,k
E
(
DID−t,`|D
))
=
k∑
`=0
T∑
t=`+2
βt
∑
g:Cg,t,k=t−`
(1−Dg,t−`−1) Ng,t
N trunS,k
E
(
Yg,t(Dg,max(t−k,1), ..., Dg,t)− Yg,t(0min(t,k+1))|D
)
−
k∑
`=0
T∑
t=`+2
βt
∑
g:Cg,t,k=t−`
Dg,t−`−1
Ng,t
N trunS,k
E
(
Yg,t(Dg,max(t−k,1), ..., Dg,t)− Yg,t(1min(t,k+1))|D
)
=
∑
g:Cg,t,k≥2
(1−Dg,t−`−1)βt Ng,t
N trunS,k
E
(
Yg,t(Dg,max(t−k,1), ..., Dg,t)− Yg,t(0min(t,k+1))|D
)
−
∑
g:Cg,t,k≥2
Dg,t−`−1βt
Ng,t
N trunS,k
E
(
Yg,t(Dg,max(t−k,1), ..., Dg,t)− Yg,t(1min(t,k+1))|D
)
. (11)
The first equality follows from the definition of DID`, and from the fact DID+t,` = DID
−
t,` = 0 for
all t ∈ {`+ 2, ..., T} if NDID` = 0. The second equality follows from the following facts. First,
DID+t,` = β
t
∑
g:Cg,t,k=t−`
(1−Dg,t−`−1) Ng,t
N trunS,k
E
(
Yg,t(Dg,max(t−k,1), ..., Dg,t)− Yg,t(0min(t,k+1))|D
)
= 0
if N `,+t = 0 or N
`,0
t = 0 and
DID−t,` = β
t
∑
g:Cg,t,k=t−`
Dg,t−`−1
Ng,t
N trunS,k
E
(
Yg,t(Dg,max(t−k,1), ..., Dg,t)− Yg,t(1min(t,k+1))|D
)
= 0
if N `,−t = 0 or N
`,1
t = 0. Second, if N
`,+
t > 0 and N
`,0
t > 0 (resp. N
`,−
t > 0 and N
`,1
t > 0),
Equation (9) (resp. (10)) holds.
The result follows from Equation (11) and the law of iterated expectations.
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